| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 生化机理 | Lersivirine (UK-453061) is a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for the treatment of HIV-1 infection. Lersivirine prevents HIV from entering the nucleus of healthy CD4 cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Lersivirine, a weak inducer of the cytochrome P450 (CYP) enzyme CYP3A4, is metabolized by CYP3A4 and UDP glucuronosyltransferase 2B7 (UGT2B7). |
| 别名 | ; |
Lersivirine,抑制剂
Lersivirine （订货以英文为准）
编号：L125187
CAS号：473921-12-9
分子式：C17H18N4O2
分子量：310.35
| 产品名称 | Lersivirine |
| 中文名称 | Lersivirine,抑制剂 |
| CAS号 | 473921-12-9 |
| 分子式（M.F.） | C17H18N4O2 |
| 分子量（M.W.） | 310.35 |
| 储存条件 | -20°C储存 |
| WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品
小艺 
